NPI: 1992966469 · NEW YORK, NY 10007 · 207LP2900X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,463 | $15K |
| 2019 | 2,503 | $69K |
| 2020 | 527 | $8K |
| 2021 | 4,633 | $119K |
| 2022 | 3,411 | $59K |
| 2023 | 2,751 | $33K |
| 2024 | 1,720 | $22K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 64483 | 923 | 891 | $45K | |
| 77002 | 1,668 | 1,198 | $39K | |
| 64636 | 257 | 230 | $28K | |
| 20610 | 1,624 | 1,135 | $25K | |
| 97530 | 736 | 323 | $25K | |
| 64635 | 270 | 242 | $24K | |
| 97110 | 875 | 411 | $23K | |
| 64484 | 910 | 876 | $20K | |
| 01936 | 211 | 191 | $19K | |
| 97140 | 725 | 339 | $17K | |
| 99213 | 1,154 | 1,101 | $17K | |
| 97112 | 432 | 205 | $13K | |
| 97162 | 126 | 126 | $12K | |
| 64493 | 101 | 81 | $5K | |
| J1040 | Methylprednisolone 80 mg inj | 1,798 | 1,621 | $4K |
| 64494 | 101 | 81 | $2K | |
| J7325 | Synvisc or synvisc-one | 59 | 25 | $2K |
| 64495 | 68 | 57 | $1K | |
| J7324 | Orthovisc inj per dose | 31 | 18 | $1K |
| 76942 | 31 | 30 | $875.12 | |
| 99204 | 40 | 40 | $799.50 | |
| J1030 | Methylprednisolone 40 mg inj | 366 | 339 | $523.44 |
| J1010 | Inj, methylpred acetate 1 mg | 227 | 208 | $318.12 |
| 99203 | 15 | 15 | $180.97 | |
| 99214 | 13 | 12 | $76.80 | |
| S0020 | Injection, bupivicaine hydro | 551 | 497 | $38.95 |
| Q9966 | Locm 200-299mg/ml iodine,1ml | 3,089 | 2,460 | $15.86 |
| J7328 | Gelsyn-3 injection 0.1 mg | 607 | 247 | $0.00 |